AVNS
Avanos Medical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AVNS
Avanos Medical, Inc.
A clinical medical devices manufacturer that provides solutions in more than 90 countries
Healthcare Equipment and Supplies
02/25/2014
10/21/2014
New York Stock Exchange
2,227
12-31
Common stock
5405 Windward Parkway, Suite 100 South , Alpharetta, GA 30004
--
Avanos Medical, Inc., is a company designed to prevent infection, promote health and wellness globalization, eliminate pain and speed recovery. The company has two business divisions: IP and Medical Devices. The Company's products and solutions are designed to address some of today's most important healthcare needs, namely preventing infection and reducing the use of anesthetics to help patients recover from surgery. The Company was established on February 25, 2014 in Delaware with the purpose of controlling Kimberly-Clark's healthcare business. Before the distribution, it and Kimberly-Clark's Clark were engaged in a series of designs, and the ownership of Kimberly-Clark's Clark's healthcare business was transferred to them. Prior to the transfer, Kimberly-Clark's Clark to their healthcare business, it will have no separation and preparation of the formation and distribution of other events outside the business.
Earnings Call
Q2/2025
Estimate EPS0.15
Actual EPS0.17
Estimate Revenue165.50M
Actual Revenue175.00M
Avanos Medical's Q2 2025: Unraveling Contradictions in HA Impact, SNS Growth, and Currency Headwinds
Aug 14,2025 06:55
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
AVNS has released its 2025 Q3 earnings. EPS was reported at 0.22, versus the expected 0.12, beating expectations. The chart below visualizes how AVNS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AVNS has released its 2025 Q3 earnings report, with revenue of 177.80M, reflecting a YoY change of 4.34%, and net profit of -1.40M, showing a YoY change of -132.56%. The Sankey diagram below clearly presents AVNS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
